Giant-Cell Arteritis Treatment Landscape: Emerging Horizons and Innovations
Giant-Cell Arteritis (GCA) is a chronic inflammatory disorder characterized by inflammation of large and medium-sized arteries. This condition primarily affects individuals over the age of 50 and can lead to serious complications if left untreated. In this blog post, we'll delve into the treatment options available for GCA, explore the current market landscape, and highlight key companies and therapies making strides in the field. Understanding Giant-Cell Arteritis Giant-Cell Arteritis, also known as temporal arteritis, presents with symptoms such as headaches, jaw pain, vision disturbances, and scalp tenderness. Prompt diagnosis and treatment are crucial to prevent complications such as vision loss and stroke. While corticosteroids are the mainstay of treatment for GCA , there is a need for alternative therapies that offer efficacy with fewer side effects. Giant-Cell Arteritis Treatment Strategies Corticosteroids, such as prednisone, are commonly prescribed to reduce inflammation